References:

1. Andrews PLR, Davis CJ. The mechanism of emesis induced by anti-cancer therapies. In: Reynolds DJM. Andrews PLR, Davis CJ, eds. Emesis in anti-cancer therapy: Mechanisms and treatment. Londond, England: Chapman and Hall Medical: 113-161: 1993.
   
   
2. Anzemet® PI. Accessed on July 25, 2001.
   
   
3. ASHP Therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. American J Health-Syst Pharm 1999;56(8):729-64.
   
   
4. Ettinger DS. Preventing chemotherapy-induced nausea and vomiting: An update and a review of emesis. Seminars in Oncology 1995;22 (4 Suppl 10):6-18.
   
   
5. Fessele KS. Managing the multiple causes of nausea and vomiting in the patient with caner. Oncol Nurs Forum 1996 Oct; 23(9):1409-15; quiz 1416-7.
   
   
6. Gralla RJ, Osoba D, Kris MG et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol. 1999; 17:2971-94.
   
   back to top
   
   
7. Gregory RE, Ettinger DS. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy. Drugs 1998;55 (2):173-89.
   
   
8. Grunberg SM, Hasketh PJ, et al. Control of chemotherapy-induced emesis. N Engl J Med 1993;329:1790-6.
   
   
9. Hesketh PJ, Kris MG, Grunberg SM, et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;15:103-9.
   
   
10. Hesketh PJ. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting. Cancer Invest 2000;18 (2):163-73.
    
    
11. King CR. Nonpharmacologic management of chemotherapy-induced nausea and vomiting. Oncol Nurs Forum 1997;24 (7 Suppl):41-8.
    
    
12. Kytril® PI. Available at http://www.rocheusa.com/products/kytril/.
    
    back to top
    
    
13. Lindley C and Blower P. Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis. Am J Health-Syst Pharm 2000; 57 (18):1685-97. Available at
    http://www.medscape.com. Accessed on July 5, 2001.
    
    
14. Morrow GR, Roscoe JA, Hickok JT, et al. Initial control of chemotherapy-induced nausea and vomiting in patient quality of life. Oncology (Huntingt) 1998;12 (3 Suppl 4):32-7.
    
    
15. National Cancer Institute. Nausea and vomiting; supportive care (patient version). Available at http://www.cancer.gov/cancer_information Accessed on July 5, 2001.
    
    
16. National Cancer Institute. Nausea and vomiting; supportive care (health professional version). Available at http://www.cancer.gov/cancer_information. Accessed on July 5, 2001.
    
    
17. Nausea and Vomiting. Available at http://www.mskcc.org. Accessed on July 27, 2001.
    
    
18. Nausea and Vomiting Treatment Guidelines for Patients with Cancer. Available at http://www.nccn.org.
    Accessed on July 5, 2001.
    
    back to top
    
    
19. OncoLink FAQ: Nausea and vomiting. Available at
    http://www.oncolink.com.
    Accessed on July 27, 2001.
    
    
20. Oncology.com: Side effect management series: Nausea and vomiting. Available at http://www.oncology.com. Accessed on July 24, 2001.
    
    
21. Palmer KJ, Poole R. Antiemetics for cancer chemotherapy-induced nausea and vomiting. Summary and table. Drugs R D 1999;2 (4):237-9.
    
    
22. Pendergrass KB. Options in the treatment of chemotherapy-induced emesis. Cancer Pract 1998;6 (5):276-81.
    
    
23. Priestman TJ. Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists. Can J Oncol 1996 Feb;6 Suppl 1:17-22.
    
    
24. Redd WH, Montgomeryy GH, DuHamel KN, et al. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst 2001 Jun 6;93(11):810-23.
    
    
25. Richardson JL, Marks G. Levine A: The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol 6:1746-1752, 1988.
    
    back to top
    
    
26. Roila F, Ciccarese G, Palladino MA, and DeAngelis V. Prevention of radiotherapy-induced emesis. Tumori 1998 Mar-Apr; 84(2): 274-8
    
    
27. Stewart DJ, Dahrouge S, Coyle D. Evans WK. Costs of treating and preventing nausea and vomiting in patients receiving chemotherapy. J Clin Oncol 1999; 17: 334-351.
    
    
28. Tavorath R and Hesketh PJ. Drug treatment of chemotherapy-induced delayed emesis. Drugs 1996;52(5):639-48.
    
    
29. Understanding Nausea and Vomiting. Available at http://www.oncology.com. Accessed on July 24, 2001.
    
    
30. Veyrat-Follet C, Farinotti R, Palmer JL. Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds. Drugs 1997;53(2):206-34.
    
    
31. Zofran® PI. Accessed on July 9, 2001.
    
    

back to top

Chemotherapy Side Effects | Radiation Side Effects | Post-Operative Side Effects | Symptom Relief | Treatment Options | References

Symptom Diary | Diet Do's & Don'ts | Questions & Answers | Tips & Facts | Handbook for Nurses | Practical Guide for Patients